Trial
NCT01438801
Predictive Value of the Insulin-like Growth Factor-1 (IGF-1) Generation Test for the Growth Response to Growth Hormone Treatment (PRED-IGF)
Phase IVWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Ipsen
Collaborators
—
Condition
Idiopathic Short Stature
Intervention
Nutropin [Somatropin (rDNA origin) for injection]
Why stopped
Participant enrollment was not feasible
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-08-05